Literature DB >> 1958072

Ranking of carcinogenic potency using a relative potency approach.

L R Glass1, C E Easterly, T D Jones, P J Walsh.   

Abstract

Protocols for long-term carcinogen bioassays have become highly refined. The ability to interpret these bioassay results beyond the experimental setting, however, has not improved commensurately. As a consequence, society is still faced with the fact that data derived in these bioassays reflect highly specific experimental conditions which are vastly different from environmental exposures of the freely roaming, outbred human. The scientific community has responded with a "collective wisdom" approach by using expert committees to interpret bioassay evidence. This committee approach is believed to be successful in protecting human health, but the list of suspected carcinogens is growing faster than the expert committees can respond. We have developed a relative potency framework for ranking the hazards represented by potential human carcinogens. The results demonstrate a rank ordering of a variety of compounds which is independent of the reference compound used to standardize the information. The philosophic basis of the approach may facilitate expert risk assessment systems development because it: (1) complements and supports "expert committee" data selection; (2) has a simple set of rules and does not require mathematical modeling; (3) requires no special situation judgments; and (4) is suitable for use with electronic data bases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958072     DOI: 10.1007/bf01055333

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  12 in total

Review 1.  Hazard evaluation for complex mixtures: relative comparisons to improve regulatory consistency.

Authors:  B A Owen; T D Jones
Journal:  Regul Toxicol Pharmacol       Date:  1990-04       Impact factor: 3.271

2.  Chemical scoring by a rapid screening of hazard (RASH) method.

Authors:  T D Jones; P J Walsh; A P Watson; B A Owen; L W Barnthouse; D A Sanders
Journal:  Risk Anal       Date:  1988-03       Impact factor: 4.000

3.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

4.  A unifying concept for carcinogenic risk assessments.

Authors:  T D Jones; G D Griffin; P J Walsh
Journal:  J Theor Biol       Date:  1983-11-07       Impact factor: 2.691

5.  Carcinogenicity testing and safety assessment.

Authors:  R A Squire
Journal:  Fundam Appl Toxicol       Date:  1984-06

Review 6.  Range of experimental evidence in assessing potential human carcinogenicity.

Authors:  I F Purchase
Journal:  Arch Toxicol Suppl       Date:  1980

7.  Animal data in hazard evaluation: paths and pitfalls.

Authors: 
Journal:  Fundam Appl Toxicol       Date:  1982 May-Jun

8.  Ranking possible carcinogenic hazards.

Authors:  B N Ames; R Magaw; L S Gold
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

9.  Animal studies and prediction of human tumors can be aided by graphical sorting of animal data: neoplastic risk from B(a)P, benzene, benzidine, and chromium.

Authors:  T D Jones; P J Walsh
Journal:  Am J Ind Med       Date:  1985       Impact factor: 2.214

10.  Toxicity, tumor promotion, and carcinogenesis in relation to excessive dosage.

Authors:  D F Flavin
Journal:  Regul Toxicol Pharmacol       Date:  1984-12       Impact factor: 3.271

View more
  3 in total

1.  Characterizing non-constant relative potency.

Authors:  Gregg E Dinse; David M Umbach
Journal:  Regul Toxicol Pharmacol       Date:  2011-05-13       Impact factor: 3.271

2.  Toxicological potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin relative to 100 other compounds: a relative potency analysis of in vitro and in vivo test data.

Authors:  T D Jones
Journal:  Arch Environ Contam Toxicol       Date:  1995-07       Impact factor: 2.804

Review 3.  Use of In Vivo and In Vitro Data to Derive a Chronic Reference Value for Crotonaldehyde Based on Relative Potency to Acrolein.

Authors:  Roberta L Grant; Allison F Jenkins
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015-11-18       Impact factor: 6.393

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.